Back
Syndax Pharmaceuticals Stock Price Chart
Free Stock Analysis Report: Get a clear concise Stock Rating
Analyze Any Stock Free
Sell
22
SNDX
Syndax Pharmaceuticals
Last Price:
$12.61
Seasonality Move:
10.52%
7 Day Trial
ALL ACCESS PASS
$
7
Free Stock Analysis Report: See The True Value of Any Stock
Analyze Any Stock Free-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SNDX is experiencing slight buying pressure.
Syndax Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 13.53 | Sell |
| 20-day SMA: | 13.33 | Sell |
| 50-day SMA: | 15.66 | Sell |
| 200-day SMA: | 19.36 | Sell |
| 8-day EMA: | 13.21 | Sell |
| 20-day EMA: | 13.69 | Sell |
| 50-day EMA: | 15.2 | Sell |
| 200-day EMA: | 18.27 | Sell |
Syndax Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.66 | Sell |
| Relative Strength Index (14 RSI): | 35.29 | Sell |
| Chaikin Money Flow: | 599596 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (12.68 - 14.66) | Sell |
| Bollinger Bands (100): | (14.83 - 20.01) | Sell |
Syndax Pharmaceuticals Technical Analysis
| Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 30 | 31 | 02 | 03 | 06 | 07 | 08 | 10 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Syndax Pharmaceuticals Stock
Is Syndax Pharmaceuticals Stock a Buy?
-
Syndax Pharmaceuticals share price is 12.60 while SNDX 8-day simple moving average is 13.53, which is a Sell signal.
-
The stock price of SNDX is 12.60 while Syndax Pharmaceuticals 20-day SMA is 13.33, which makes it a Sell.
-
Syndax Pharmaceuticals 50-day simple moving average is 15.66 while SNDX share price is 12.60, making it a Sell technically.
-
SNDX stock price is 12.60 and Syndax Pharmaceuticals 200-day simple moving average is 19.36, creating a Sell signal.
SNDX Technical Analysis vs Fundamental Analysis
Sell
22
Syndax Pharmaceuticals (SNDX)
is a Sell
Is Syndax Pharmaceuticals a Buy or a Sell?
-
Syndax Pharmaceuticals stock is rated a SellThe current Syndax Pharmaceuticals [SNDX] share price is $12.60. The Score for SNDX is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
Syndax Pharmaceuticals Stock Info
Market Cap:
1.1B
Price in USD:
12.60
Share Volume:
2.1M
Syndax Pharmaceuticals 52-Week Range
52-Week High:
25.34
52-Week Low:
12.40
Sell
22
Syndax Pharmaceuticals (SNDX)
is a Sell
Syndax Pharmaceuticals Share Price Forecast
-
What is the Syndax Pharmaceuticals stock price today?The Syndax Pharmaceuticals stock price is 12.60 USD today.
-
Will SNDX stock go up or go down?Syndax Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Syndax Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Syndax Pharmaceuticals is overvalued.
Is Syndax Pharmaceuticals Stock a Buy?
-
Syndax Pharmaceuticals share price is 12.60 while SNDX 8-day exponential moving average is 13.21, which is a Sell signal.
-
The stock price of SNDX is 12.60 while Syndax Pharmaceuticals 20-day EMA is 13.69, which makes it a Sell.
-
Syndax Pharmaceuticals 50-day exponential moving average is 15.20 while SNDX share price is 12.60, making it a Sell technically.
-
SNDX stock price is 12.60 and Syndax Pharmaceuticals 200-day simple moving average is 18.27, creating a Sell signal.
Fundamental Analysis of Syndax Pharmaceuticals
Is Syndax Pharmaceuticals a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.00 per share, and an increase next year of $1.26 per share.
Technical Analysis of Syndax Pharmaceuticals
Should I short Syndax Pharmaceuticals stock?
-
SNDX Moving Average Covergence Divergence (MACD) indicator is -0.66, suggesting Syndax Pharmaceuticals is a Sell
-
Syndax Pharmaceuticals Relative Strength Index (RSI) is 35.29, which suggest Syndax Pharmaceuticals is oversold
-
The Bollinger Bands (25) for Syndax Pharmaceuticals is (12.68 - 14.66), which suggest Syndax Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Syndax Pharmaceuticals is (14.83 - 20.01), which suggest Syndax Pharmaceuticals is a Sell
* Syndax Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.